Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 95 Pages
Report ld: 3472209
Request Sample
Customized Report
Metronidazole Market Size(US$)

CAGR 2025-2031
-0.5%
Market Size,2031
USD 108
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Metronidazole was valued at US$ 112 million in the year 2024 and is projected to reach a revised size of US$ 108 million by 2031, growing at a CAGR of -0.5% during the forecast period.
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Global Metronidazole key players include CordenPharma Farchemia, Tongji Pharmaceutical, Aarti Drugs, Manav Drugs, etc.
China is the largest market, with a share about 90%, followed by India, and Europe, both have a share over 10 percent.
In terms of product, Glyoxal Process is the largest segment, with a share over 85%. And in terms of application, the largest application is Metronidazole Tablets, followed by Metronidazole Capsule, Metronidazole Injection, etc.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Metronidazole, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metronidazole.
The Metronidazole market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Metronidazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Metronidazole manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Hongyuan Pharmaceutical
Yinhe Aarti Pharmaceutical
Saikang Pharmaceutical
Zhongan Pharmaceutical
Wuyao Pharmaceutical
Yichang Changjiang Pharmaceutical
Tongji Pharmaceutical
Hongda Pharmaceutical
Topsun Pharmaceutical
Unichem Laboratories
CordenPharma Farchemia
API Polpharma
Manav Drugs
Aarey Drugs & Pharmaceuticals
Aarti Drugs
Segment by Type
Glyoxal Process
Ethidene Diamine Process
Others
Segment by Application
Metronidazole Tablets
Metronidazole Capsule
Metronidazole Injection
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Metronidazole manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Metronidazole in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Metronidazole Market Overview
1.1 Product Definition
1.2 Metronidazole by Type
1.2.1 Global Metronidazole Market Value Comparison by Type (2024 VS 2031)
1.2.2 Glyoxal Process
1.2.3 Ethidene Diamine Process
1.2.4 Others
1.3 Metronidazole by Application
1.3.1 Global Metronidazole Market Value by Application (2024 VS 2031)
1.3.2 Metronidazole Tablets
1.3.3 Metronidazole Capsule
1.3.4 Metronidazole Injection
1.3.5 Others
1.4 Global Metronidazole Market Size Estimates and Forecasts
1.4.1 Global Metronidazole Revenue 2020-2031
1.4.2 Global Metronidazole Sales 2020-2031
1.4.3 Global Metronidazole Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Metronidazole Market Competition by Manufacturers
2.1 Global Metronidazole Sales Market Share by Manufacturers (2020-2025)
2.2 Global Metronidazole Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Metronidazole Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Metronidazole, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Metronidazole, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Metronidazole, Product Type & Application
2.7 Global Key Manufacturers of Metronidazole, Date of Enter into This Industry
2.8 Global Metronidazole Market Competitive Situation and Trends
2.8.1 Global Metronidazole Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Metronidazole Players Market Share by Revenue
2.8.3 Global Metronidazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Metronidazole Market Scenario by Region
3.1 Global Metronidazole Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Metronidazole Sales by Region: 2020-2031
3.2.1 Global Metronidazole Sales by Region: 2020-2025
3.2.2 Global Metronidazole Sales by Region: 2026-2031
3.3 Global Metronidazole Revenue by Region: 2020-2031
3.3.1 Global Metronidazole Revenue by Region: 2020-2025
3.3.2 Global Metronidazole Revenue by Region: 2026-2031
3.4 North America Metronidazole Market Facts & Figures by Country
3.4.1 North America Metronidazole Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Metronidazole Sales by Country (2020-2031)
3.4.3 North America Metronidazole Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Metronidazole Market Facts & Figures by Country
3.5.1 Europe Metronidazole Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Metronidazole Sales by Country (2020-2031)
3.5.3 Europe Metronidazole Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Metronidazole Market Facts & Figures by Region
3.6.1 Asia Pacific Metronidazole Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Metronidazole Sales by Region (2020-2031)
3.6.3 Asia Pacific Metronidazole Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Metronidazole Market Facts & Figures by Country
3.7.1 Latin America Metronidazole Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Metronidazole Sales by Country (2020-2031)
3.7.3 Latin America Metronidazole Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Metronidazole Market Facts & Figures by Country
3.8.1 Middle East and Africa Metronidazole Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Metronidazole Sales by Country (2020-2031)
3.8.3 Middle East and Africa Metronidazole Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Metronidazole Sales by Type (2020-2031)
4.1.1 Global Metronidazole Sales by Type (2020-2025)
4.1.2 Global Metronidazole Sales by Type (2026-2031)
4.1.3 Global Metronidazole Sales Market Share by Type (2020-2031)
4.2 Global Metronidazole Revenue by Type (2020-2031)
4.2.1 Global Metronidazole Revenue by Type (2020-2025)
4.2.2 Global Metronidazole Revenue by Type (2026-2031)
4.2.3 Global Metronidazole Revenue Market Share by Type (2020-2031)
4.3 Global Metronidazole Price by Type (2020-2031)
5 Segment by Application
5.1 Global Metronidazole Sales by Application (2020-2031)
5.1.1 Global Metronidazole Sales by Application (2020-2025)
5.1.2 Global Metronidazole Sales by Application (2026-2031)
5.1.3 Global Metronidazole Sales Market Share by Application (2020-2031)
5.2 Global Metronidazole Revenue by Application (2020-2031)
5.2.1 Global Metronidazole Revenue by Application (2020-2025)
5.2.2 Global Metronidazole Revenue by Application (2026-2031)
5.2.3 Global Metronidazole Revenue Market Share by Application (2020-2031)
5.3 Global Metronidazole Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Hongyuan Pharmaceutical
6.1.1 Hongyuan Pharmaceutical Company Information
6.1.2 Hongyuan Pharmaceutical Description and Business Overview
6.1.3 Hongyuan Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Hongyuan Pharmaceutical Metronidazole Product Portfolio
6.1.5 Hongyuan Pharmaceutical Recent Developments/Updates
6.2 Yinhe Aarti Pharmaceutical
6.2.1 Yinhe Aarti Pharmaceutical Company Information
6.2.2 Yinhe Aarti Pharmaceutical Description and Business Overview
6.2.3 Yinhe Aarti Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Yinhe Aarti Pharmaceutical Metronidazole Product Portfolio
6.2.5 Yinhe Aarti Pharmaceutical Recent Developments/Updates
6.3 Saikang Pharmaceutical
6.3.1 Saikang Pharmaceutical Company Information
6.3.2 Saikang Pharmaceutical Description and Business Overview
6.3.3 Saikang Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Saikang Pharmaceutical Metronidazole Product Portfolio
6.3.5 Saikang Pharmaceutical Recent Developments/Updates
6.4 Zhongan Pharmaceutical
6.4.1 Zhongan Pharmaceutical Company Information
6.4.2 Zhongan Pharmaceutical Description and Business Overview
6.4.3 Zhongan Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Zhongan Pharmaceutical Metronidazole Product Portfolio
6.4.5 Zhongan Pharmaceutical Recent Developments/Updates
6.5 Wuyao Pharmaceutical
6.5.1 Wuyao Pharmaceutical Company Information
6.5.2 Wuyao Pharmaceutical Description and Business Overview
6.5.3 Wuyao Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Wuyao Pharmaceutical Metronidazole Product Portfolio
6.5.5 Wuyao Pharmaceutical Recent Developments/Updates
6.6 Yichang Changjiang Pharmaceutical
6.6.1 Yichang Changjiang Pharmaceutical Company Information
6.6.2 Yichang Changjiang Pharmaceutical Description and Business Overview
6.6.3 Yichang Changjiang Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Yichang Changjiang Pharmaceutical Metronidazole Product Portfolio
6.6.5 Yichang Changjiang Pharmaceutical Recent Developments/Updates
6.7 Tongji Pharmaceutical
6.7.1 Tongji Pharmaceutical Company Information
6.7.2 Tongji Pharmaceutical Description and Business Overview
6.7.3 Tongji Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Tongji Pharmaceutical Metronidazole Product Portfolio
6.7.5 Tongji Pharmaceutical Recent Developments/Updates
6.8 Hongda Pharmaceutical
6.8.1 Hongda Pharmaceutical Company Information
6.8.2 Hongda Pharmaceutical Description and Business Overview
6.8.3 Hongda Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hongda Pharmaceutical Metronidazole Product Portfolio
6.8.5 Hongda Pharmaceutical Recent Developments/Updates
6.9 Topsun Pharmaceutical
6.9.1 Topsun Pharmaceutical Company Information
6.9.2 Topsun Pharmaceutical Description and Business Overview
6.9.3 Topsun Pharmaceutical Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Topsun Pharmaceutical Metronidazole Product Portfolio
6.9.5 Topsun Pharmaceutical Recent Developments/Updates
6.10 Unichem Laboratories
6.10.1 Unichem Laboratories Company Information
6.10.2 Unichem Laboratories Description and Business Overview
6.10.3 Unichem Laboratories Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Unichem Laboratories Metronidazole Product Portfolio
6.10.5 Unichem Laboratories Recent Developments/Updates
6.11 CordenPharma Farchemia
6.11.1 CordenPharma Farchemia Company Information
6.11.2 CordenPharma Farchemia Description and Business Overview
6.11.3 CordenPharma Farchemia Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CordenPharma Farchemia Metronidazole Product Portfolio
6.11.5 CordenPharma Farchemia Recent Developments/Updates
6.12 API Polpharma
6.12.1 API Polpharma Company Information
6.12.2 API Polpharma Description and Business Overview
6.12.3 API Polpharma Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.12.4 API Polpharma Metronidazole Product Portfolio
6.12.5 API Polpharma Recent Developments/Updates
6.13 Manav Drugs
6.13.1 Manav Drugs Company Information
6.13.2 Manav Drugs Description and Business Overview
6.13.3 Manav Drugs Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Manav Drugs Metronidazole Product Portfolio
6.13.5 Manav Drugs Recent Developments/Updates
6.14 Aarey Drugs & Pharmaceuticals
6.14.1 Aarey Drugs & Pharmaceuticals Company Information
6.14.2 Aarey Drugs & Pharmaceuticals Description and Business Overview
6.14.3 Aarey Drugs & Pharmaceuticals Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Aarey Drugs & Pharmaceuticals Metronidazole Product Portfolio
6.14.5 Aarey Drugs & Pharmaceuticals Recent Developments/Updates
6.15 Aarti Drugs
6.15.1 Aarti Drugs Company Information
6.15.2 Aarti Drugs Description and Business Overview
6.15.3 Aarti Drugs Metronidazole Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Aarti Drugs Metronidazole Product Portfolio
6.15.5 Aarti Drugs Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Metronidazole Industry Chain Analysis
7.2 Metronidazole Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Metronidazole Production Mode & Process Analysis
7.4 Metronidazole Sales and Marketing
7.4.1 Metronidazole Sales Channels
7.4.2 Metronidazole Distributors
7.5 Metronidazole Customer Analysis
8 Metronidazole Market Dynamics
8.1 Metronidazole Industry Trends
8.2 Metronidazole Market Drivers
8.3 Metronidazole Market Challenges
8.4 Metronidazole Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 93
USD 4250.00
(Single User License)
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 123
USD 2900.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 119
USD 3950.00
(Single User License)
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 168
USD 4900.00
(Single User License)
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 154
USD 5900.00
(Single User License)
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 123
USD 3950.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-17
Pages: 179
USD 5600.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-16
Pages: 170
USD 5900.00
(Single User License)
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published Date: 2024-04-07
Pages: 115
USD 4900.00
(Single User License)
The global Metronidazole market size was US$ 111 million in 2025 and is forecast to reach a readjusted size of US$ 108 million by 2032 with a CAGR of -0.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 93
The global Metronidazole market was valued at US$ 111 million in 2025 and is anticipated to reach US$ 108 million by 2032, at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 123
The global market for Metronidazole was estimated to be worth US$ 111 million in 2025 and is projected to reach US$ 108 million, growing at a CAGR of -0.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 119
The global Metronidazole market is projected to grow from US$ 112 million in 2024 to US$ 108 million by 2031, at a CAGR of -0.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 168
In 2024, the global market size of Metronidazole was estimated to be worth US$ 112 million and is forecast to reach approximately US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 154
The global Metronidazole market size was US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
The global market for Metronidazole was estimated to be worth US$ 112 million in 2024 and is forecast to a readjusted size of US$ 108 million by 2031 with a CAGR of -0.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 123
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-17
Pages: 179
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-16
Pages: 170
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
Published: 2024-04-07
Pages: 115
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now